Yaxuan Wang

6PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 22, 2026
HSPB6: A Potential Prognostic Biomarker, Inhibiting the Epithelial-Mesenchymal Transition (EMT) Process Through the PI3K/Akt Signaling Pathway Based on the Machine Learning and Experimental Validation.

|Feb 16, 2026
Unraveling Signaling Pathways in Immune Microenvironment Crosstalk to Overcome Immunotherapy Resistance in Colorectal Cancer.

Hui Zhang, Jingjing Shao, Tianye Zhao

|Dec 29, 2025
Extracellular Vesicle-Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion.

Jingwei Zhao, Jiayun Zhu, Ziyi Yang

|May 18, 2024
Common immunological and prognostic features of lung and bladder cancer via smoking-related genes: PRR11 gene as potential immunotherapeutic target.

YaXuan Wang, HaiXia Zhu, Lu Zhang

|Mar 20, 2024
Unveiling the role of YARS1 in bladder cancer: A prognostic biomarker and therapeutic target.

YaXuan Wang, Jinfeng Wang, Lu Zhang

|Oct 27, 2022
A Pan-Cancer Analysis of Heat-Shock Protein 90 Beta1(HSP90B1) in Human Tumours.

Yaxuan Wang, Xiaolin Wang

Pageof 1

Frequent Collaborators

2 joint publications

MingHua Ren

2 joint publications

Haixia Zhu

1 joint publications

Jing-Wei Zhao

1 joint publications

Jia Yun Zhu